Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Klaria Pharma Holding

0.81 SEK

+3.05 %

Less than 1K followers

KLAR

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Klaria Pharma Holding

2019202020212022202320242025
Revenue4.25.92.39.0
growth-%299.3 %
EBITDA-11.0-35.3-39.1-43.9-14.7-31.2-
EBIT-21.1-48.7-50.1-55.0-14.7-31.2-25.2
Profit before taxes-22.5-51.4-53.5-63.7-18.4-47.7-38.9
Net income-22.5-51.4-53.5-63.8-18.4-47.8-38.9
EPS-0.66-0.91-0.94-1.07-0.18-0.37-0.21
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-260.5 %-748.6 %-1,387.1 %
EBIT-%-499.5 %-936.5 %-1,387.1 %-280.7 %
ROE-27.4 %-46.9 %-77.1 %-83.8 %-44.7 %-1,442.6 %1,002.5 %
ROI-22.1 %-38.8 %-45.2 %-53.0 %-25.2 %-83.4 %-95.4 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.